Items where the Publication is The Lancet Infectious diseases
Number of items: 15.
Public
Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study. (2023)
Beshir, Khalid B; Muwanguzi, Julian; Nader, Johanna; Mansukhani, Raoul; Traore, Aliou; Gamougam, Kadidja; Ceesay, Sainey; Bazie, Thomas; Kolie, Fassou; Lamine, Mahaman M; Cairns, Matt; Snell, Paul; Scott, Susana; Diallo, Abdoulaye; Merle, Corinne S; NDiaye, Jean Louis; Razafindralambo, Lanto; Moroso, Diego; Ouedraogo, Jean-Bosco; Zongo, Issaka; Kessely, Hamit; Doumagoum, Daugla; Bojang, Kalifa; Ceesay, Serign; Loua, Kovana; Maiga, Hamma; Dicko, Alassane; Sagara, Issaka; Laminou, Ibrahim M; Ogboi, Sonny Johnbull; Eloike, Tony; Milligan, Paul; Sutherland, Colin J
Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study. (2022)
Cerqueira-Silva, Thiago; Andrews, Jason R; Boaventura, Viviane S; Ranzani, Otavio T; de Araújo Oliveira, Vinicius; Paixão, Enny S; Júnior, Juracy Bertoldo; Machado, Tales Mota; Hitchings, Matt DT; Dorion, Murilo; Lind, Margaret L; Penna, Gerson O; Cummings, Derek AT; Dean, Natalie E; Werneck, Guilherme Loureiro; Pearce, Neil; Barreto, Mauricio L; Ko, Albert I; Croda, Julio; Barral-Netto, Manoel
Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial. (2022)
Datoo, Mehreen S; Natama, Hamtandi Magloire; Somé, Athanase; Bellamy, Duncan; Traoré, Ousmane; Rouamba, Toussaint; Tahita, Marc Christian; Ido, N Félix André; Yameogo, Prisca; Valia, Daniel; Millogo, Aida; Ouedraogo, Florence; Soma, Rachidatou; Sawadogo, Seydou; Sorgho, Faizatou; Derra, Karim; Rouamba, Eli; Ramos-Lopez, Fernando; Cairns, Matthew; Provstgaard-Morys, Samuel; Aboagye, Jeremy; Lawrie, Alison; Roberts, Rachel; Valéa, Innocent; Sorgho, Hermann; Williams, Nicola; Glenn, Gregory; Fries, Louis; Reimer, Jenny; Ewer, Katie J; Shaligram, Umesh; Hill, Adrian VS; Tinto, Halidou
Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational study. (2018)
Fifer, Helen; Cole, Michelle; Hughes, Gwenda; Padfield, Simon; Smolarchuk, Christa; Woodford, Neil; Wensley, Adrian; Mustafa, Nazim; Schaefer, Ulf; Myers, Richard; Templeton, Kate; Shepherd, Jill; Underwood, Anthony
Oropharyngeal Neisseria gonorrhoeae infections: should women be routinely tested? (2021)
Fifer, Helen; Hughes, Gwenda
Lessons learnt from ceftriaxone-resistant gonorrhoea in the UK and Australia. (2020)
Fifer, Helen; Hughes, Gwenda; Whiley, David; Lahra, Monica M
Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study. (2022)
Fink, Douglas L; Callaby, Helen; Luintel, Akish; Beynon, William; Bond, Helena; Lim, Eleanor Y; Gkrania-Klotsas, Effrossyni; Heskin, Jospeh; Bracchi, Margherita; Rathish, Balram; Milligan, Iain; O'Hara, Geraldine; Rimmer, Stephanie; Peters, Joanna R; Payne, Lara; Mody, Nisha; Hodgson, Bethany; Lewthwaite, Penny; Lester, Rebecca; Woolley, Stephen D; Sturdy, Ann; Whittington, Ashley; Johnson, Leann; Jacobs, Nathan; Quartey, John; Ai Payne, Brendan; Crowe, Stewart; Elliott, Ivo Am; Harrison, Thomas; Cole, Joby; Beard, Katie; Cusack, Tomas-Paul; Jones, Imogen; Banerjee, Rishi; Rampling, Tommy; Specialist and High Consequence Infectious Diseases Centres Netw; Dunning, Jake
Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark. (2022)
Hansen, Christian Holm; Friis, Nikolaj Ulrik; Bager, Peter; Stegger, Marc; Fonager, Jannik; Fomsgaard, Anders; Gram, Mie Agermose; Christiansen, Lasse Engbo; Ethelberg, Steen; Legarth, Rebecca; Krause, Tyra Grove; Ullum, Henrik; Valentiner-Branth, Palle
Why development of outbreak analytics tools should be valued, supported, and funded. (2021)
Jombart, Thibaut
Diagnostic capacity for invasive fungal infections in advanced HIV disease in Africa: a continent-wide survey. (2022)
Lakoh, Sulaiman; Kamudumuli, Pocha Samuel; Penney, Richard OS; Haumba, Samson M; Jarvis, Joseph N; Hassan, Asha Jama; Moudoute, Ngando Laure E; Ocansey, Bright K; Izco, Santiago; Kipkerich, Stephen; Sacarlal, Jahit; Awopeju, Abimbola T; Govender, Nelesh P; Munyanji, Cleophas If Malaba; Guyguy, Kamwiziku; Orefuwa, Emma; Denning, David W
Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial. (2023)
Madhi, Shabir A; Kwatra, Gaurav; Richardson, Simone I; Koen, Anthonet L; Baillie, Vicky; Cutland, Clare L; Fairlie, Lee; Padayachee, Sherman D; Dheda, Keertan; Barnabas, Shaun L; Bhorat, Qasim Ebrahim; Briner, Carmen; Ahmed, Khatija; Aley, Parvinder K; Bhikha, Sutika; Bhorat, AE; Esmail, Aliasgar; Horne, Elizea; Kaldine, Haajira; Mukendi, Christian K; Madzorera, Vimbai Sharon; Manamela, Nelia P; Masilela, Mduduzi; Hermanus, S Tandile; Motlou, Thopisang; Mzindle, Nonkululeko; Oelofse, Suzette; Patel, Faeezah; Rhead, Sarah; Rossouw, Lindie; Taoushanis, Carol; van Eck, Samuel; Lambe, Teresa; Gilbert, Sarah C; Pollard, Andrew J; Moore, Penny L; Izu, Alane
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial. (2022)
Munro, Alasdair PS; Feng, Shuo; Janani, Leila; Cornelius, Victoria; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A; Kanji, Nasir; Libri, Vincenzo; Llewelyn, Martin J; McGregor, Alastair C; Maallah, Mina; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Bawa, Tanveer; Saralaya, Dinesh; Sharma, Sunil; Sheridan, Ray; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Snape, Matthew D; Liu, Xinxue; Faust, Saul N; COV-BOOST study group
Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010-15: a population-based, longitudinal study. (2020)
Ranzani, Otavio T; Rodrigues, Laura C; Bombarda, Sidney; Minto, Cátia M; Waldman, Eliseu A; Carvalho, Carlos RR
Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study. (2022)
Swarthout, Todd D; Henrion, Marc YR; Thindwa, Deus; Meiring, James E; Mbewe, Maurice; Kalizang'Oma, Akuzike; Brown, Comfort; Msefula, Jacquline; Moyo, Brewster; Mataya, Andrew A; Barnaba, Susanne; Pearce, Emma; Gordon, Melita; Goldblatt, David; French, Neil; Heyderman, Robert S
Effectiveness of a pay-it-forward intervention compared with user-paid vaccination to improve influenza vaccine uptake and community engagement among children and older adults in China: a quasi-experimental pragmatic trial. (2022)
Wu, Dan; Jin, Chenqi; Bessame, Khaoula; Tang, Fanny Fong-Yi; Ong, Jason J; Wang, Zaisheng; Xie, Yewei; Jit, Mark; Larson, Heidi J; Chantler, Tracey; Lin, Leesa; Gong, Wenfeng; Yang, Fan; Jing, Fengshi; Wei, Shufang; Cheng, Weibin; Zhou, Yi; Ren, Nina; Qiu, Shuhao; Bao, Jianmin; Wen, Liufen; Yang, Qinlu; Tian, Junzhang; Tang, Weiming; Tucker, Joseph D